NASDAQ:ACT Enact (ACT) Price, Holdings, & News $37.24 -0.21 (-0.55%) As of 03:07 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Enact (NASDAQ:ACT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Enact alerts:Sign Up Key Stats Today's Range$37.12▼$37.4250-Day Range$34.25▼$38.2552-Week Range$30.79▼$38.55Volume93,214 shsAverage Volume406,635 shsMarket Capitalization$5.49 billionAssets Under Management$12.40 millionDividend Yield2.26%Net Expense Ratio0.75%Aggregate RatingN/A ETF Overview Enact Holdings, Inc. operates as a private mortgage insurance company in the United States. It engages in writing and assuming residential mortgage guaranty insurance. The company also offers private mortgage insurance products primarily insuring prime-based, individually underwritten residential mortgage loans; contract underwriting services for mortgage lenders; and mortgage-related reinsurance products. It primarily serves originators of residential mortgage loans. The company was formerly known as Genworth Mortgage Holdings, Inc. and changed its name to Enact Holdings, Inc. in May 2021. Enact Holdings, Inc. was founded in 1981 and is headquartered in Raleigh, North Carolina. Enact Holdings, Inc. operates as a subsidiary of Genworth Holdings Inc. Read More Enact ExpensesTypeACTTheme ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.60%0.57%0.56%0.54%0.53%Other Expenses0.31%0.57%0.56%0.52%0.56%Total Expense0.91%0.74%0.76%0.73%0.73%Fee Waiver-0.16%-0.76%-0.66%-0.50%-0.63%Net Expense0.75%0.60%0.63%0.63%0.60% Receive ACT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Enact and its competitors with MarketBeat's FREE daily newsletter. Email Address ACT ETF News HeadlinesUttarakhand to enact law to recognise all minority institutions, repeal Madarsa Board ActAugust 18 at 7:36 AM | msn.comLegislature overrides governor's veto to enact controversial law: 'An awful turning point'August 15 at 6:10 AM | msn.comWashington Thinks They Own Your Bank AccountWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.August 18 at 2:00 AM | Priority Gold (Ad)Shelter at full capacity, forced to enact rescue freezeAugust 14, 2025 | msn.comWash Post editorial sees possible short term success in Trump's decision to send National Guard to DCAugust 13, 2025 | msn.comMarcos urges Congress to 'swiftly enact' P6.793-T 2026 budget | INQTodayAugust 13, 2025 | msn.comSee More Headlines ACT ETF - Frequently Asked Questions How have ACT shares performed this year? Enact's stock was trading at $32.38 at the start of the year. Since then, ACT stock has increased by 15.1% and is now trading at $37.28. How were Enact's earnings last quarter? Enact Holdings, Inc. (NASDAQ:ACT) released its quarterly earnings results on Wednesday, July, 30th. The company reported $1.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.11 by $0.04. The company earned $304.89 million during the quarter, compared to the consensus estimate of $307.54 million. Enact had a net margin of 55.35% and a trailing twelve-month return on equity of 13.61%. Read the conference call transcript. Is Enact buying back stock? Enact's Board of Directors authorized a stock buyback plan on Wednesday, April 30th 2025, which authorizes the company to repurchase $350,000,000 in outstanding shares, according to EventVestor. This means that the company could buy up to 6.5% of its stock through open market purchases. Stock buyback plans are typically a sign that the company's leadership believes its shares are undervalued. When did Enact IPO? Enact (ACT) raised $253 million in an IPO on Thursday, September 16th 2021. The company issued 13,310,400 shares at $19.00 per share. Who are Enact's major shareholders? Top institutional shareholders of Enact include Arrowstreet Capital Limited Partnership (0.78%), Geode Capital Management LLC (0.59%), First Trust Advisors LP (0.52%) and Allianz Asset Management GmbH (0.51%). Insiders that own company stock include Genworth Holdings, Inc, Rohit Gupta, Brian Gould and James Mcmullen. View institutional ownership trends. How do I buy shares of Enact? Shares of ACT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Enact own? Based on aggregate information from My MarketBeat watchlists, some other companies that Enact investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), Adobe (ADBE), ServiceNow (NOW) and e.l.f. Beauty (ELF). Fund Details IssuerAdvisorShares Fund NameAdvisorShares Vice ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:ACT Inception Date12/12/2017 Fund ManagerDan S. Ahrens, Robert M. Parker Webnew.mortgageinsurance.genworth.com Phone919-846-4100Fund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelDeveloped Markets RegionNorth America Number of Holdings0 Fund Statistics Assets Under Management$12.40 million Average Daily Volume$1.65 thousand Discount/Premium0.00% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorAdvisorShares Investments, LLC CustodianThe Bank of New York Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerN/A Miscellaneous Outstanding Shares147,510,000Beta0.57 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report ACT Sector ExposureACT Industry Exposure This page (NASDAQ:ACT) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersBiotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B marketA small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of...Smallcaps Daily | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | Sponsored"AI Upgrade" Coming Sept. 1stA new “AI Upgrade” is rolling out on September 1st—and tech leaders are calling it transformational. Softbank’...Behind the Markets | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enact Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enact With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access